Package 82381-2000-8

Brand: bexagliflozin

Generic: bexagliflozin
NDC Package

Package Facts

Identity

Package NDC 82381-2000-8
Digits Only 8238120008
Product NDC 82381-2000
Product ID 82381-2000_8e571636-526b-4d31-a8ac-c19014a59f9c
Description

30 TABLET in 1 BOTTLE (82381-2000-8)

Marketing

Marketing Status
Marketed Since 2024-03-19
Brand bexagliflozin
Generic bexagliflozin
Sample Package No

Linked Drug Pages (1)

Bexagliflozin ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "8e571636-526b-4d31-a8ac-c19014a59f9c", "openfda": {"nui": ["N0000187059", "N0000187058"], "unii": ["EY00JF42FV"], "rxcui": ["2637859"], "spl_set_id": ["7f0ad5d2-3509-4057-904c-d27993de7408"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["TheracosBio, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (82381-2000-8)", "package_ndc": "82381-2000-8", "marketing_start_date": "20240319"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (82381-2000-9)", "package_ndc": "82381-2000-9", "marketing_start_date": "20240319"}], "brand_name": "Bexagliflozin", "product_id": "82381-2000_8e571636-526b-4d31-a8ac-c19014a59f9c", "dosage_form": "TABLET", "pharm_class": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "82381-2000", "generic_name": "Bexagliflozin", "labeler_name": "TheracosBio, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bexagliflozin", "active_ingredients": [{"name": "BEXAGLIFLOZIN", "strength": "20 mg/1"}], "application_number": "NDA214373", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20240319", "listing_expiration_date": "20261231"}